PASI scores, photographic documentation, and symptom tracking provide objective measures of progress
The enteroendocrine "letter cells" - time for a new nomenclature
"Patients who combine medication with consistent lifestyle changesrather than relying on pharmacology aloneare more likely to achieve and maintain substantial, long-term health improvements." Nutrient intake is another thing to consider when starting GLP-1s
It selectively inhibits CYP11B2 (aldosterone synthase), preventing aldosterone synthesis before the hormone even exists
GLP-1 risks While GLP-1 drugs are generally safe, especially for people with diabetes or obesity, they can cause side effects like nausea or, in some cases, loss of muscle mass, which is a concern for older adults
Peptide detection poses challenges for anti-doping programs, while increasing consumer availability accentuates the need for supplement quality assurance